Clinical Trial Update: Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports results from a Phase 1/2 study evaluating a combination of sirolimus, cisplatin, and gemcitabine hydrochloride in patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine hydrochloride (Gemcitabine hydrochloride)
• Sirolimus (Sirolimus)

Snippet

Sponsor: University of Washington | Conditions: Recurrent Bladder Carcinoma, Stage II Bladder Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-10-20